homocysteine has been researched along with rosiglitazone in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (70.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aslan, E; Bagis, T; Erkanli, S; Haydardedeoglu, B; Kilicdag, EB; Tarim, E; Zeyneloglu, HB | 1 |
Agrawal, KC; Chattergoon, NN; Diez, JG; Dunne, JB; Fonseca, NA; Fonseca, VA; Jeter, JR; Kadowitz, PJ; McNamara, DB; Mondal, D; Murthy, SN; Obregon, DF | 1 |
Arslan, M; Ayvaz, G; Bukan, N; Cakir, N; Karakoç, A; Törüner, F; Yilmaz, M | 1 |
Hitoglou-Makedou, AD; Kazakos, KA; Lasaridis, AN; Mouslech, TF; Nilsson, PM; Sarafidis, PA; Stafylas, PC; Tourkantonis, AA; Yovos, JG | 1 |
Ceska, R; Dolezalova, R; Kasalova, Z; Krejci, H; Stulc, T | 1 |
Duan, S; Liu, F; Liu, H; Liu, Y; Peng, Y; Wang, H | 1 |
Ciccarelli, L; Cicero, AF; D'Angelo, A; Derosa, G; Ferrari, I; Gravina, A; Montagna, L; Paniga, S; Piccinni, MN; Pricolo, F; Ragonesi, PD; Salvadeo, SA | 1 |
Kaur, T; Pal Singh, A; Singh Bedi, PM; Singh, N; SinghDahiya, R | 1 |
Atamer, A; Atamer, Y; Can, AS; Hekimoğlu, A; Ilhan, N; Koçyiğit, Y; Yenice, N | 1 |
Dai, W; Li, P; Liu, LY; Tu, JH; Wang, SX; Yang, XH; Yin, YL | 1 |
5 trial(s) available for homocysteine and rosiglitazone
Article | Year |
---|---|
Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
Topics: Adult; Anovulation; Blood Glucose; Body Weight; Female; Folic Acid; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Luteinizing Hormone; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones; Vitamin B 12 | 2005 |
The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Topics: Adult; Androgens; Antioxidants; Blood Glucose; Body Mass Index; Body Weight; Female; Homeostasis; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Malondialdehyde; Metformin; Models, Statistical; Oxidative Stress; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Smoking; Thiazolidinediones; Time Factors | 2005 |
The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
Topics: Aged; Arteriosclerosis; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypoglycemic Agents; Lipoprotein(a); Male; Middle Aged; Risk Factors; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones | 2005 |
Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Metabolic Syndrome; Metformin; Middle Aged; Pioglitazone; Rosiglitazone; Thiazolidinediones | 2006 |
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus.
Topics: Aged; Aryldialkylphosphatase; Biomarkers; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Male; Malondialdehyde; Metabolome; Metformin; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Triglycerides | 2013 |
5 other study(ies) available for homocysteine and rosiglitazone
Article | Year |
---|---|
Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet.
Topics: Animals; Carotid Arteries; Catheterization; Cell Division; Cystathionine beta-Synthase; Diet; DNA; Female; Homocysteine; Hyperplasia; Ligands; Liver; Methionine; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Tunica Intima | 2005 |
Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes.
Topics: Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Homocysteine; Humans; Hypoglycemic Agents; Kidney; Male; Middle Aged; Rosiglitazone; Thiazolidinediones | 2005 |
Inhibitory effect of PPAR-gamma activator on IL-6 and mPGES protein expression in PBMC induced by homocysteine.
Topics: Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Homocysteine; Humans; Interleukin-6; Intramolecular Oxidoreductases; Kidney Failure, Chronic; Leukocytes, Mononuclear; Microsomes; PPAR gamma; Prostaglandin-E Synthases; Renal Dialysis; Rosiglitazone; Thiazolidinediones; Troglitazone | 2005 |
Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Homocysteine; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Methionine; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2010 |
Rosiglitazone via PPARγ-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone.
Topics: Animals; Aorta, Thoracic; Blotting, Western; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Homocysteine; Human Umbilical Vein Endothelial Cells; Humans; Male; Microscopy, Fluorescence; NADPH Oxidases; NF-kappa B; Oxidative Stress; PPAR gamma; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Vasodilation | 2015 |